Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shibeshih Belachew

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Plos One|April 20, 2012
Motor fatigue measurement by distance-induced slow down of walking speed in multiple sclerosisRémy Phan-Ba, Philippe Calay, Patrick Grodent, et al.
Hearing Research|October 9, 2007
Strategies to regenerate hair cells: identification of progenitors and critical genesIngrid Breuskin, Morgan Bodson, Nicolas Thelen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 28, 2002
Cyclin-dependent kinase-2 controls oligodendrocyte progenitor cell cycle progression and is downregulated in adult oligodendrocyte progenitorsShibeshih Belachew, Adan A Aguirre, Hang Wang, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 21, 2011
MRI preclinical detection and asymptomatic course of a progressive multifocal leucoencephalopathy (PML) under natalizumab therapyRémy Phan-Ba, Emilie Lommers, Luaba Tshibanda, et al.
Frontiers in Cellular Neuroscience|August 20, 2024
New views on the complex interplay between degeneration and autoimmunity in multiple sclerosisPeter K Stys, Shigeki Tsutsui, Arie R Gafson, et al.
BMC Neuroscience|March 31, 2009
Period 2 regulates neural stem/progenitor cell proliferation in the adult hippocampusLaurence Borgs, Pierre Beukelaers, Renaud Vandenbosch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 30, 2022
Recurrent disability progression endpoints in multiple sclerosis clinical trialsAlexandra Bühler, Marcel Wolbers, Fabian Model, et al.
Multiple Sclerosis and Related Disorders|June 7, 2020
Exploring the Impact of Fatigue in Progressive Multiple Sclerosis: A Mixed-Methods AnalysisIris-Katharina Penner, Fiona McDougall, T Michelle Brown, et al.
Mental Retardation and Developmental Disabilities Research Reviews|June 30, 2006
The Yin and Yang of cell cycle progression and differentiation in the oligodendroglial lineageLaurent Nguyen, Laurence Borgs, Renaud Vandenbosch, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 18, 2014
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme resultsHelmut Butzkueven, Ludwig Kappos, Fabio Pellegrini, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Plos One|April 20, 2012
Motor fatigue measurement by distance-induced slow down of walking speed in multiple sclerosisRémy Phan-Ba, Philippe Calay, Patrick Grodent, et al.
Hearing Research|October 9, 2007
Strategies to regenerate hair cells: identification of progenitors and critical genesIngrid Breuskin, Morgan Bodson, Nicolas Thelen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 28, 2002
Cyclin-dependent kinase-2 controls oligodendrocyte progenitor cell cycle progression and is downregulated in adult oligodendrocyte progenitorsShibeshih Belachew, Adan A Aguirre, Hang Wang, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 21, 2011
MRI preclinical detection and asymptomatic course of a progressive multifocal leucoencephalopathy (PML) under natalizumab therapyRémy Phan-Ba, Emilie Lommers, Luaba Tshibanda, et al.
Frontiers in Cellular Neuroscience|August 20, 2024
New views on the complex interplay between degeneration and autoimmunity in multiple sclerosisPeter K Stys, Shigeki Tsutsui, Arie R Gafson, et al.
BMC Neuroscience|March 31, 2009
Period 2 regulates neural stem/progenitor cell proliferation in the adult hippocampusLaurence Borgs, Pierre Beukelaers, Renaud Vandenbosch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 30, 2022
Recurrent disability progression endpoints in multiple sclerosis clinical trialsAlexandra Bühler, Marcel Wolbers, Fabian Model, et al.
Multiple Sclerosis and Related Disorders|June 7, 2020
Exploring the Impact of Fatigue in Progressive Multiple Sclerosis: A Mixed-Methods AnalysisIris-Katharina Penner, Fiona McDougall, T Michelle Brown, et al.
Mental Retardation and Developmental Disabilities Research Reviews|June 30, 2006
The Yin and Yang of cell cycle progression and differentiation in the oligodendroglial lineageLaurent Nguyen, Laurence Borgs, Renaud Vandenbosch, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 18, 2014
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme resultsHelmut Butzkueven, Ludwig Kappos, Fabio Pellegrini, et al.
Pageof 9